Early treatment with recombinant factor VIIa results in greater efficacy with less product.
- Published in:
- European Journal of Haematology, 1998, v. 61, n. S63, p. 7, doi. 10.1111/j.1600-0609.1998.tb01103.x
- By:
- Publication type:
- Article
Works matching IS 09024441 AND DT 1998 AND VI 61 AND IP S63
Results: 6
1
2
Introduction.
- Published in:
- European Journal of Haematology, 1998, v. 61, n. S63, p. 5, doi. 10.1111/j.1600-0609.1998.tb01102.x
- By:
- Publication type:
- Article
3
Approaches towards successful home treatment in patients with inhibitors.
- Published in:
- European Journal of Haematology, 1998, v. 61, n. S63, p. 11, doi. 10.1111/j.1600-0609.1998.tb01104.x
- By:
- Publication type:
- Article
4
Pharmaco-economic aspects of inhibitor treatment.
- Published in:
- European Journal of Haematology, 1998, v. 61, n. S63, p. 24, doi. 10.1111/j.1600-0609.1998.tb01107.x
- By:
- Publication type:
- Article
5
Immune tolerance induction: a role for recombinant activated factor VII (rFVIIa)?
- Published in:
- European Journal of Haematology, 1998, v. 61, n. S63, p. 18, doi. 10.1111/j.1600-0609.1998.tb01106.x
- By:
- Publication type:
- Article
6
Optimal care of inhibitor patients during surgery.
- Published in:
- European Journal of Haematology, 1998, v. 61, n. S63, p. 15, doi. 10.1111/j.1600-0609.1998.tb01105.x
- By:
- Publication type:
- Article